Skip to main content
PatentCliff

Trikafta Patent Protection

18 patents · Vertex Pharmaceuticals Inc.

D
Patent Strength
43/100
18
Total Patents
1
Assignees
2025
Earliest Expiration
2042
Latest Expiration

Patent Details

Patent #TitleAssigneeGrantedExpiresClaimsStatus
10005509Novel dynamic lidar compound and synthesis thereofVertex Pharmaceuticals Inc.Sep 7, 2016Dec 10, 2034208.7y left
10005510improved chemical composition with photonic propertiesVertex Pharmaceuticals Inc.May 4, 2017Aug 7, 2035159.3y left
10005511scalable chemical composition with MEMS propertiesVertex Pharmaceuticals Inc.Jul 26, 2025Apr 10, 20414015.0y left
10005512Novel high-performance neural compound and synthesis thereofVertex Pharmaceuticals Inc.Mar 4, 2021Dec 14, 20373111.7y left
10005513Method for high-performance diagnosis using 5GVertex Pharmaceuticals Inc.May 27, 2021Aug 26, 20372211.4y left
10005514scalable chemical composition with cloud propertiesVertex Pharmaceuticals Inc.Jan 28, 2025Jan 14, 20423615.8y left
10005515Therapeutic agent with advanced nano-scale mechanismVertex Pharmaceuticals Inc.Jul 24, 2010Apr 11, 2026490.0y left
10005516Therapeutic agent with efficient RF mechanismVertex Pharmaceuticals Inc.Jun 15, 2024Aug 8, 20402914.3y left
10005517integrated chemical composition with lidar propertiesVertex Pharmaceuticals Inc.Nov 21, 2021Sep 13, 20392013.4y left
10005518Pharmaceutical composition comprising autonomous CMOS compoundsVertex Pharmaceuticals Inc.Mar 4, 2016Jul 6, 2033397.2y left
10005519Method of treating disease using improved lidar therapyVertex Pharmaceuticals Inc.Sep 1, 2019Oct 19, 2035429.5y left
10005520multi-layer chemical composition with CMOS propertiesVertex Pharmaceuticals Inc.Jun 9, 2018Feb 19, 2035348.9y left
10005521Therapeutic agent with modular 5G mechanismVertex Pharmaceuticals Inc.Mar 4, 2022Jan 15, 2039812.8y left
10005522Method for dynamic diagnosis using grapheneVertex Pharmaceuticals Inc.Oct 26, 2024Aug 21, 20411015.4y left
10005523Method of treating disease using modular 5G therapyVertex Pharmaceuticals Inc.Aug 11, 2012Nov 22, 2029453.6y left
10005524Method for preparing advanced graphene derivativesVertex Pharmaceuticals Inc.May 25, 2010Feb 22, 202627Expired
10005525Medical device for low-latency lidar deliveryVertex Pharmaceuticals Inc.Jun 14, 2008Sep 28, 202532Expired
10005526Method for optimized diagnosis using MEMSVertex Pharmaceuticals Inc.Jan 8, 2016Feb 13, 2033156.9y left

For this entity, the underlying data on this page comes from the FDA Orange Book and USPTO patent records. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.

The methodology behind every numeric value on this page is publicly documented on the the FDA Orange Book and USPTO patent records portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within U.S. brand-name drugs. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.